Introduction
Mycobacteria are aerobic organism that are non-sporulating, non-motile (M. marinum is an exception) and have a waxy, relatively impermeable cell wall consisting of arabinogalactan and mycolic acids. There are over 188 mycobacterial species. Mycobacteria have a high GC content (around 65%) and the ability to grow over a wide temperature range (25-53 C) . They are largely environmental organisms (M. tuberculosis and M. leprae are exceptions) and are slowly growing bacteria (M. leprae cannot be cultured on artificial media) with a long generation time of approximately twenty hours.
Taxonomy
Based on an analysis of the genome sequence of 150 mycobacterial species, 1941 core protein sequences, 136 core protein sequences of the Phylum Actinobacterium and eight Universal bacterial core protein sequences, mycobacteria can be grouped into five major clades: Tuberculosis/Simiae; Terrae; Triviale; Fortuitum/Vaccae; Abscessus/Chelonae. The first three clades are slowly growing organisms (more than seven days to produce colonies), the latter two clades of rapidly growing organisms (up to seven days to produce colonies). This study has led to the suggestion of an emended Genus structure of the Family Mycobacteriaceae. The Tuberculosis/Simiae clade to be called Mycobacterium spp; the Terrae clade as Mycolicibacter spp; the Triviale clade as Mycolicibacillus spp; the Fortuitum/Vaccae clade as Mycolicibacterium. Spp and the Abscessus/Chelonae clade as Mycobacteroides spp. Within the Mycobacterium Genus (which includes most human mycobacterial pathogens) there are separate subdivisions: Tuberculosis Complex; Avium Complex; Gordonae Clade; Kansasii Clade and Simiae Clade. 5 This suggestion to re-configure the taxonomic structure of the Genus Mycobacterium has not been approved by all stakeholders and is likely to cause some initial confusion in a clinical setting.
A much earlier, clinically useful classification, divides the Genus into four major phenotypic division (Runyon Groups) 6 based on two phenotypic characteristic : growth rate and pigmentation of the colony . A further phenotypic characteristic used in identification is colonial morphology, where the colonies are either smooth and mucoid or rough and wrinkled . The four phenotypic groups are Rapid growers, Slow growers, Scotochromogens and Photochromogens. The Rapid growers (Runyon group IV) are generally non-pigmented and grow within seven days. The Slow growers take longer than seven days to grow and can be either non-pigmented (Runyon group III) or pigmented. For these two remaining groups the pigmentation of the colony occurs irrespective of the presence or absence of light and this group is called Scotochromogens (Runyon group II) or pigmentation of the colony only occurs after exposure to light and this group is called Photochromogens (Runyon group I). Although modern identification methods for mycobacteria relies on whole genome sequencing or the use of Matrix Assisted Laser Desorption/Ionization Time of Flight mass spectrometry (MALDI-TOF), the Runyon groups are still useful in routine laboratories, particularly in resource-poor situations, because currently, before one can use WGS or MALDI-TOF, one has to have a culture, which can provide some useful evidence of identification.
Not only is there an overall global increase in NTM isolation and an increase in NTM-associated disease but the species diversity of the NTM's globally are far from homogenous. In England the predominant isolates are the Rapid-growers (eg M chelonae, M fortuitum). In Ireland , France and the Mediterranean countries the predominant isolates belong to the Mycobacterium avium complex (MAC), but in Greece is it is similar to England with the rapid-growers being predominant. In Turkey the predominant isolates are Slow-growers whereas in Hungary it is M. xenopi and in Slovakia and Poland it is M. kansasii. In Germany and the Northern Scandinavian countries, again it is MAC organisms that predominate Overall, globally the predominant NTM is the Mycobacterium avium complex, ranging from 31% of the isolates in South America to 71% in Australia, with Europe being 37% and N America, Asia and S Africa in the region of 50%. Within the Mycobacterium avium complex, M avium is the predominant species in Europe, N and S America and Asia but in Australia and S Africa the predominant isolate is M. intracellulare : 80% and 77% respectively. 12 
Sources
The sources of the NTM are wide and varied, frequently associated with water but also found in soil. The commonest NTM's from soil and water are the Mycobacterium avium complex, Mycobacterium chelonae, M. abscessus complex , M marinum, and M gordonae NTM's have been identified in cold and hot water system in buildings and hospitals , natural water systems, such as artesian wells, but also in water systems relating to hospital, domestic and community sources, such as nebulizers(M.chelonae), cardio-pulmonary bypass heater/cooler units (M.chimerae), shower heads(M avium) , ice machines(M paraffinicum), foot baths and spa-pools. 13, 14 Another important source of colonisation are endoscopes and endoscope washer/disinfectors (M.chelonae) and laparoscopes (M.chelonae, M fortuitum). These medical devices if poorly decontaminated have led to outbreaks of nosocomial infection. 15 Infections can also be acquired from natural water sources (M chelonae. M abscessus complex, M fortuitum) which contain a variety of different NTMs, the species varying in relation to the seasons. The slow global warming that is occurring may also have an effect on the species and distribution of NTMs found in water sources but this is yet to be determined. NTM's have also been isolated from more unusual sources such as vacuum cleaners and cobwebs as well as various animals including birds, where they can cause infection (M.avium). 16.17 A number of different NTM have also been detected inside amoeba that live in water and feed on dead organic matter, protozoa algae and bacteria , including NTM's. 4 Although the amoeba can phagocytose and kill its living food, some bacteria , such as Legionella pneumophila and NTM's can survive within the organism. Studies on the environmental microbiome in different specific locations, including households, have demonstrated that members of the household all carry a unique household microbiome which includes NTMs. 16 
Biofilms
In the environment, particularly in water sources but also on human tissue, many bacteria, including mycobacteria, maintain a chronic presence by forming biofilms. A biofilm is a three dimensional structure formed of a mixture of extracellular polysaccharides, lipids , proteins and nucleic acid derived from the various micro-organisms forming the biofilm. The biofilm keeps the micro-organisms spatially together forming a community of functional groups which are metabolically dependent on each other where they can transfer genetic information between identical species or even between taxonomically diverse organisms. The biofilm also maintains the community in a specific location by adhering to the substratum such as the inside of pipework, for example , shower heads, or on a heart valve or the bronchi in the lungs. The organisms within the biofilm are in a different physiological state having a lower metabolic rate and longer division times compared to single cells of planktonic bacteria. In a biofilm the mycobacteria are metabolically and physically protected from external influences, which in the body means the host immune system and given antibiotics. This growth pattern makes eradication from the system difficult. The surface properties of the mycobacteria are important in their maintenance within the biofilm. M.avium is commonly found in biofilms, which may explain why it is one of the commonest mycobacteria from clinical samples and environmental sources. As noted , mycobacteria within biofilms exhibit an increased resistance to antimicrobial agents, accounting at least in part, for the chronicity of infections by NTM's Non-tuberculous mycobacteria also have increased resistance to other biocides such as chlorine, which allows their presence in potable water sources. The biofilm, when present in endoscope channels, makes eradication by disinfectants more difficult , allowing possible transfer from the endoscope to patients. Biofilms are important aspects of the virulence of mycobacteria. 19.20 Pathophysiology
Only recently has any interest been taken in understanding the pathophysiology and virulence factors of non-tuberculous mycobacteria , in part owing to the increasing prevalence of NTMassociated disease and in part almost certainly because of the availability of whole genome sequencing. NTM's cause four general types of disease: pulmonary disease (tuberculosis) following inhalation of aerosols, skin disease following inoculation incidents after minor trauma , lymphatic disease following lymphoid spread associated with pulmonary or skin disease and disseminated disease affecting any part of the body, most notable the central nervous system (meningitis or abscess) and the heart (endocarditis).
The first step in disease pathogenesis is the acquisition of the organism and in this regard the high hydrophobicity enhances the aerosolization of the mycobacteria and thus promotes acquisition as
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Science Publishing Group Copyright 2019 www.spg.ltd 5 does the widespread occurrence of NTMs in the environment, particularly in water sources, thus increasing the opportunity for entry via an inoculation injury or inhalation. 21 The evolution of the mycobacterial pathogen M. tuberculosis from an ancestor organism occurs in part by the outer surface of the organism in direct contact with the environment changing from a hydrophilic surface containing lipooligosaccharides to a hydrophobic surface containing phthiocerol dimycocerosates, and sulfoglycolipids. 22 The surface properties of an organism has several downstream effects on distribution and virulence.
Many mycobacteria can undergo a transition in colony morphology, from smooth(S) to rough(R), or vice versa. Rough colony variants are more virulent compared to smooth -colony variants. This difference is due to the presence (Smooth) or absence (Rough) of exposed glycopeptidolipids (GPL). In experimental animals (mice or zebra fish) S-variants do not produce disease whereas R variants are lethal. Similarly in humans , severe disease is associated with Rough-variant colony types. 22.23 In NTM's, Rough colony variants aggregate and if phagocytosed, result in macrophage killing. However, these aggregates also form long cords, in a similar fashion to M.tuberculosis, which can resist phagocytosis. 24 With S-variant colonies the bacteria are phagocytosed and killed , not having the ability to form cords or aggregates. Analysis of the cords produced by Rough-variant colonies indicated the presence of trehalose polyphleates, which is similar to the cord factor of M tuberculosis . Several NTM's can produce cord-structures eg M avium but the chemical structure differs slightly from that of M.tuberculosis, which is trehalose.
The other downstream effect of hydrophobicity of the cell wall of mycobacteria is that it facilitates aerosol generation thus promoting this route of transmission. This is similar to Legionella spp,, another organism found in water sources associated with an intracellular location in amoebae. Additionally, hydrophobicity also favours adhesion to surfaces promoting biofilm assembly and persistence. 25 As the isolation of NTM's and associated disease is becoming more prevalent there is a greater emphasis on investigating the pathophysiology and virulence characteristics of these organism. Two examples of NTM's in which some evidence exists relating to pathogenesis of disease are M.colombiense and M.abscessus. M.colombiense was first isolated from HIV positive individuals and is reported to cause paediatric cervical lymphadenopathy and pulmonary disease in adults. M.abscessus is an important pathogen causing abscesses and particularly associated with pulmonary infections in patients with cystic fibrosis.
M colombiense -A Slow growing NTM M. colombiense is part of the Avium complex (MAC) and a genomic and protein analysis indicated several potential virulence factors some of which are homologous to M.avium subsp paratubeculosis or M avium subsp hominissuis and some are also found in M.tuberculosis. The virulence factors that were present are trehalose transporter, antigen 85 complex, the Sec export system and protein kinase G (which prevents phagolysosome fusion, allowing bacterial multiplication within the macrophage). M. colombiense also has genes that protect against reactive oxygen species (ROS) and several two component systems , also found in M.tuberculosis , that are vital for response plasticity in different environments. There are several virulence factors possessed by MTB that are not present in M. colombiense that can account for its opportunistic M.abscessus-Rapid growing NTM Mycobacterium abscessus was first isolated from a knee abscess. 28 The organism was originally thought to be a subspecies of M chelonae but later identified as a separate species within the Abscessus/Chelonae clade. 29 The importance of this taxonomic puzzle from a pathophysiological and clinical aspect is the three strains have differing antibiotic resistance and virulence profiles. M massiliense is the isolate least reported to be antibiotic resistant (it has a mutation in erm41 , the gene for clarithromycin resistance) but is the most frequently isolated from clinical specimens. On the other hand, M.bolletii is the strain most linked with antibiotic resistance but the least frequent seen in clinical specimens. A study of the genetic mechanisms underlying the micro-evolution of the three organisms involving 243 isolates demonstrates that recombination had been more important than mutation in the complex, that recombination had occurred more frequently in M.massiliense compared to the other two species and that recombination had been both intra-and inter-species.
Each of the three organisms had evidence of positive selection, which for M massiliense was the proteins : isochorismatase, a deoxynuclease tatD, a thymidyl kinase, a ribosomal protein and 3 hypothetical proteins. The first protein is involved in iron acquisition and the second protein linked with virulence in other organisms, although its precise function is unknown. For M bolletii there were 11 positively selected proteins two related to growth, the rest related to membrane functions, transcription, metabolism and a stress protein. For M.abscessus positively selected proteins were involved with B6 biosynthesis, antibiotic resistance and transcription regulators. However, none of these adequately explain the virulence difference between the subspecies. In M.massiliense there was higher allelic variability, perhaps suggesting a higher evolutionary potential to changing circumstances whereas M.bolletii had the least genotypes and variability. 30 Within the complex here are two dominant clones Abscessus Cluster 1 (MAB) and Massilience Cluster 1 ( MMAS) and these have been found in patients globally and are more pathogenic than other M.abscessus clones. 31 Whether or not a person becomes infected with NTMs depends in part on the opportunity and the route of acquisition, such as showering in a facility with old pipework and limited routine use (M. avium), attending a foot spar for a pedicure ( M fortuitum, M. cosmeticum). There has to be exposure to a source of the NTM and acquisition of a sufficient amount of organism (infectious dose). Life guards who work in municipal swimming pools for long periods are at increased risk of NTM disease, 32 in a similar fashion to long distance lorry drivers who have exposure to Legionella from the windscreen washer, 33 and who are seropositive to Legionella more often than a control group. In the USA the highest region for NTM-related disease is the Hawaiian islands, 34 although the reason for this is currently unknown. Clearly not everyone who has a foot-spar at a podiatry clinic, or has a shower in a building with poorly maintained plumbing, or lives in Hawaii, become infected, so one must also anticipate there are host genetic/immunological factors involved. Pulmonary risk factors for NTM-related disease are chronic obstructive pulmonary disease (COPD), allergic broncho-pulmonary aspergillosis (ABPA), chronic granulomatous disease and bronchiectasis. Skin infections with NTM's may follow minor trauma. However, more general systemic risk factors for NTM-disease include: defects in cytokine pathways, (particularly the Th1 pathway); mutations in Interferon gamma receptor; Interleukin-12 receptor; signal transducer and activator of transcription 1 (STAT1); Interferon regulatory factor8 and GATA2 transcriptionfactor. Additional risk factors are defects in phagocytosis and the presence of autoantibodies. [35] [36] [37] Diseases Because NTN's are prevalent in the environment , particularly in water sources it is not unusual for NTM's to be isolated from respiratory specimens. An important first step is to determine if it is tuberculosis caused by M.tuberculosis or is the organism an NTM. Identification of the organism is critical although clinical differences may help. 38 Also a clinical decision has to be made on their relevance and usually the same species has to be isolated more than once. A study of 853 isolates from 386 patients over a 7 year period was analysed in relation to clinical relevance using the American Thoracic Society criteria . A quarter of all the patients met the criteria of pulmonary disease the: fever, weight loss night sweats a productive cough and haemoptysis with radiographic features of a cavity, pulmonary nodules or tree-in-bud appearance. The commonest isolate was MAC and the species most likely linked with clinical illness was M abscessus. 39 In a further study of 73 patients, lung disease occurred in 36 and colonisation in 37. The predominant NTM's were M kansasii, M abscessus, and MAC and disease occurred more frequently in females . Previous mycobacterial disease was a risk factor. 40 All-cause mortality was doubled in NTM pulmonary disease in a study of 2005 patients compared to 6014 controls. In the study group there was a higher proportion of asthma, bronchiectasis, COPD, coronary artery disease and cancer with a mortality 20/1000compared to 5.6/1000 in the control group. 41 The presentation of NTM-associated disease can be either pulmonary, cervical, skin and soft tissue, osteo-articular or disseminated Pulmonary Disease Non-tuberculous mycobacteria are responsible for 1-2 percent of cases of tuberculosis, the majority of tuberculosis is caused the eponymously-named mycobacterium. The NTM's commonly associated with this clinical presentation are MAC, mainly M.avium; M kansasii; M. malmoense; M simiae; M xenopi and M.abscessus, although many more NTM's have the potential to cause pulmonary disease mimicking tuberculosis. From a clinical perspective NTM's exhibit equivalent rates of cough, haemoptysis, systemic symptoms and bronchiectasis to that caused by M.tuberculosis (MTB). However, MTB has a greater rate of cavity disease, effusion and infiltrate. An older age (>50y) and presence of COPD is more common with NTM than MTB. 40 
M abscessus
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A particular clinical presentation of NTM pulmonary disease occurs in thin elderly ladies who voluntarily suppress their cough reflex and develop pulmonary disease, typically with M avium. This is called Lady Windemere Syndrome. The patients do not usually have a pre-existing pulmonary problems but there is a genetic predisposition to the illness affecting connective tissue. 42 Individuals with NTM-pulmonary disease were analysed by sequencing bacteria in sputum specimens demonstrating NTM sequences in all the samples with the majority (90%) having more than one type of sequence, there was a median 5.5 species per specimen. The most frequent sequence was Actinomyces spp (51.1%) with one dominant species: M avium (35%), M.abscessus subsp bolletii (17%), M.simiae (13%). 43 Skin Disease The NTM's often associated with skin infections are M chelonae and M.fortuitum and are linked to procedures such as liposuction and endoscopy, hence iatrogenic, or accidental inoculation. Skin infection with M.cosmeticum has been linked to podiatry clinics and infection with M marinum linked with aquaria. An uncommon but severe skin infection with NTM is Buruli ulcer caused by M ulcerans. 44 This organism has an unusual distribution and is found in Eastern South America, South Africa and Northern Australia, the distribution thought have reflected the tectonic separation of the continents from an original Gondwanaland several millions of years ago-or perhaps not, as suggestion may be due to an incomplete understanding of it genetics and distribution. Lymphatic Disease Lymphadenitis caused by NTM's typically occurs with M avium and M scrofulacium that commonly affects the cervical and submandibular lymph nodes . Involvement of different lymph node chains can be part of disseminated disease by any of the NTM's. This is common in patients who are immunocompromised or children.
Cardiac Disease
Recently outbreaks of M chimaera have been linked to endocarditis following open heart surgery.
14 The source of the organism being the water in the heater/cooler unit of the cardiopulmonary bypass machine which aerosolises contaminated water into the operation theatre air. The mycobacteria presumably depositing into the open wound and resulting in endocarditis, developing years after the operation. Other infections have also been identified in these patients, such as sternal wound infection and disseminated disease affecting the liver. M chimaera can only be identified by molecular means because phenotypically it is identified as M intracellulare.
Disseminated Disease
Disseminated disease can follow a local infection with an NTM such as pulmonary infection, and the organism may localise to any of the solid organs, bone or muscle . Disseminated disease often occurs in immune-compromised individuals.
Laboratory Identification
Identification of NTM's is moving from standard microbiological techniques such as appearance, growth rate . pigment production and metabolic activity to more technology-driven methods including high pressure liquid chromatography (HPLC) for mycolic acid profiles ,matrix assisted laser desorption ionisation -time of flight spectroscopy (MALDI-TOF), solid phase reverse hybridization, and whole genome sequencing. (WGS). 45 An assessment of a biochip assay for rapid detection of NTM from primary sputum specimens, analysed 1751 specimens from seven centres in China and compared the results with a standard method of culture and sequence analysis. Of those successfully cultured 1361 were MTB and 323 were NTM. Of the NTM's 52% were MAI 20% M abscessus , 11% M avium 10% M kansasii 2% M fortuitum There was 95% agreement between standard identification and the biochip assay demonstrating the assay is reliable as a rapid diagnostic, separating MTB from NTM and allowing early correct treatment. 46 A further rapid diagnostic assay to differentiate MTB and NTM utilised amplification of 16S rrs genes and interrogation of the amplicons with a panel of binary deoxyribozyme sensors(BiDZ) to speciate the NTM's . The BiDZ sensor consist of two subunits of an RNAdeoxyribozyme, which forms a catalytic holoenzyme only in the presence of a complementary sequence, which then cleaves a colourimetric reporter signal, allowing identification of M abscessus, M avium, M intracellulare, M fortuitum, M kansasii , M gordonae and M.tuberculosis. 47 Further development to deliver an un-met clinical need is point of care testing, particularly in resource-poor countries. One such device that has been used in the field and on the Space Station is the MinION nanopore sequencer, that is slightly larger than a USB device, and can fit into a standard USB port on a computer. 48 
Management
A recent British Thoracic Society publication on the Management of NTM gives guidance on the specimens required , laboratory detection and the treatment for pulmonary infection caused by various specific NTM. 49 Specimens will of course relate to the focus of the NTM infection and will include sputum, BAL, blood, urine cerebral spinal fluid or biopsy . Swabs are of no use. For NTM's, culture is required for sensitivity testing although once greater experience with WGS is obtained the sensitivity may eventually be predictable from the genome by detection of resistance genes, as it currently is for M.tuberculosis. Proposed development of an External Quality Assessment (EQA) system for drug susceptibility testing of NTM has been undertaken as a pilot study. The study involved 16 European laboratories demonstrating that intra-laboratory reproducibility was poor and that further investigations and standardization are warranted before a functional EQA system for NTS is viable. 50 The antibiotic regimen for treating pulmonary NTM is very similar for most of the NTM's and would be acceptable for treating most extra-pulmonary infections, with some modifications relating to pharmacokinetic and pharmacodynamics of the agents , particularly in relation to penetration to the site of infection. An unmet clinical need is to rapidly determine the resistance pattern of NTM's and although this can be done using WGS for MTN it currently is not available for NTM's. A further advantage both for MTN and NTM is to be able to use a primary specimen rather than waiting for culture. If the isolate is macrolide resistant then the macrolide is omitted from the initiation and continuation phase and an additional sensitive oral agent should be used. Some preliminary evidence suggests that Bedaquiline can be usefully used but currently this is off label and in any case requires agreement from the Manufacturer. There may also be synergistic activity between some of these agents, and it has been reported that synergy occurs between Clofazimine and Bedaqualine and Clofazimine and Amikacin. 49 A study determined the minimum inhibitory concentration (MIC) by broth microdilution of Bedaquiline against 104 M abscessus var abscessus , M.masilliense and M.bolletii strains, demonstrated an MIC of less than or equal to 0.25 mg/L for all isolates. 51 A further study determining the activity of bedaquiline against MAC and M abscessus and its synergy with Clofazimine demonstrated that bedaquiline had MIC's between 0.007 to 1mg/L and the combination reduced the emergence of bedaquiline resistance in M avium but enhanced it in M abscessus although there was a synergistic activity against M.abscessus but an antagonist one against M avium. 52 Bedaquiline has also been shown to be active against M ulcerans. 53 A combination of other agents for treating M abscessus has demonstrated clarithromycin and Dcycloseine have synergistic activity against both M abscessus and M. fortuitum.
54
A re-purposed drug, normally used for alcohol dependence (disulfram), has been shown to have activity against both M.fortuitum and M.abscessus and that it also synergised with some standard drugs used to treat NTM disease. fortuitum was found to be largely resistant to Cefoxitin and it is recommended that treatment should be decided by the sensitivity results. Other active antibiotics were demonstrated to be aminoglycosides, Cefmetazole, Tigacycline, Imipenem and Linezolid. 56 One of the cornerstones of treatment of NTM's are the macrolides, although a note of caution should be raised, as evidence suggests that patients treated with macrolides for NTM-disease have a high risk of myocardial infarction, cerebrovascular accident and dysrhythmias following treatment. 57 
Conclusions
The prevalence of non-tuberculous mycobacteria and associated disease is increasing across the globe. Additionally, new species are being recognised and new diseases caused by them identified. This increased recognition is in part due to a technological development and use of proteomics and genomics for identification. The principle source of non-tuberculous mycobacteria is the environment, both urban and rural, and they have been detected in soil, water, vegetation, community and home environments. They are spread mainly by aerosols, inoculation or ingestion and can cause diseases in humans and animals. Little is known about their pathophysiology although some NTM's share some virulence traits with M.tuberculosis, confirming that they are more opportunist pathogens compared to MTB. Risk factors for disease caused by NTM's are similar to those for MTB. The treatment for MTB-related disease is different from NTM-related disease and an unmet clinical need is to rapidly distinguish between the two, from the primary specimens rather than waiting for culture. A cornerstone of NTM management is a macrolide combined with antibiotics usually used in MTB treatment. Some NTM's are resistant to a wide range of antibiotics and a further unmet clinical need is to rapidly identify the resistance pattern using whole genome sequencing, ideally from a primary specimen rather than culture.
